Literature DB >> 6319114

Effects of long-term antiepileptic therapy on the hypothalamic-pituitary axis in man.

M Franceschi, L Perego, F Cavagnini, A G Cattaneo, C Invitti, F Caviezel, L F Strambi, S Smirne.   

Abstract

Effects of long-term antiepileptic therapy on the hypothalamic-pituitary axis were evaluated from the basal and stimulated plasma levels of growth hormone (GH) and prolactin (PRL) and from circadian adrenocorticotropic hormone (ACTH)/cortisol rhythms. Data for patients with well-controlled epilepsy of mild-to-moderate severity were compared with those for normal healthy volunteers. Analysis of the effects of each antiepileptic drug (AED) and of combined AEDs revealed minor abnormalities of stimulated GH secretion in all treated patients. In epileptic men, all individual AEDs (except valproate) and AED polytherapy increased both basal and stimulated plasma levels of PRL. In epileptic women, this effect was more variable and less marked, probably because of early depletion of PRL reserves. Each AED and combined AEDs did not significantly change circadian ACTH/cortisol rhythms in epileptic patients. The effects observed seem not to be related to epilepsy per se. Clinical implications, pathways, and neurotransmitters involved and possible mechanisms of the neuroendocrine effects of long-term AED therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319114     DOI: 10.1111/j.1528-1157.1984.tb04154.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  Multiple intracranial lipoma: a case report.

Authors:  J Hädecke; M Buchfelder; H J Triebel; U Schneyer
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

2.  Endocrine function changes in young males during long-term antiepileptic therapy with phenobarbitone and carbamazepine.

Authors:  L Rozza; A Marcolla; G Ferrari
Journal:  Ital J Neurol Sci       Date:  1987-08

3.  Luteinizing hormone pulsatile secretion and pituitary response to gonadotropin releasing hormone and to thyrotropin releasing hormone in male epileptic subjects on chronic phenobarbital treatment.

Authors:  G Murialdo; R Manni; A De Maria; M L Bonura; A Polleri; A Tartara
Journal:  J Endocrinol Invest       Date:  1987-02       Impact factor: 4.256

4.  Genetic differences in maternal behaviour patterns in mice administered phenobarbital during pregnancy.

Authors:  G Laviola; K Sedowofia; J Innes; R Clayton; A Manning
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 5.  Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.

Authors:  Jouko I T Isojärvi; Erik Taubøll; Andrew G Herzog
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Serum prolactin response to metoclopramide during status epilepticus.

Authors:  U Lindbom; T Tomson; B Y Nilsson; D E Andersson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

Review 7.  Pregnancy, epilepsy, and anticonvulsants.

Authors:  Bernhard J Steinhoff
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

8.  Serum prolactin concentrations and epilepsy. A study which compares healthy subjects with a group of patients in presurgical evaluation and circadian variations with those related to seizures.

Authors:  J Bauer; H Stefan; U Schrell; B Uhlig; S Landgraf; U Neubauer; B Neundörfer; W Burr
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

9.  Phenobarbitone: adverse effects on reproductive performance and offspring development in the Mongolian gerbil, (Meriones unguiculatus).

Authors:  J B Chapman; M G Cutler
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Sexual dysfunction in women with epilepsy.

Authors:  Vivek Karan; S Harsha; B S Keshava; R Pradeep; T S Sathyanarayana Rao; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2015 Jul-Sep       Impact factor: 1.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.